Exome Sequencing Reveals Comprehensive Genomic Alterations across Eight Cancer Cell Lines

Open Access

Peer-reviewed

Research Article

Han Chang ,

* E-mail: Han.Chang@bms.com

Affiliation Research and Development, Bristol-Myers Squibb Company, Princeton, New Jersey, United States of America
⨯
Donald G. Jackson,

Affiliation Research and Development, Bristol-Myers Squibb Company, Princeton, New Jersey, United States of America
⨯
Paul S. Kayne,

Affiliation Research and Development, Bristol-Myers Squibb Company, Princeton, New Jersey, United States of America
⨯
Petra B. Ross-Macdonald,

Affiliation Research and Development, Bristol-Myers Squibb Company, Princeton, New Jersey, United States of America
⨯
Rolf-Peter Ryseck,

Affiliation Research and Development, Bristol-Myers Squibb Company, Princeton, New Jersey, United States of America
⨯
Nathan O. Siemers

Affiliation Research and Development, Bristol-Myers Squibb Company, Princeton, New Jersey, United States of America
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer genomics
Is the Subject Area "Cancer genomics" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Single nucleotide polymorphisms
Is the Subject Area "Single nucleotide polymorphisms" applicable to this article?

Thanks for your feedback.
Genome sequencing
Is the Subject Area "Genome sequencing" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Human genomics
Is the Subject Area "Human genomics" applicable to this article?

Thanks for your feedback.
Mutation databases
Is the Subject Area "Mutation databases" applicable to this article?

Thanks for your feedback.